MedImaging Integrated Solution Inc. (6796.TW) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · Taiwan
MedImaging Integrated Solution Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 538.92 m TWD | 661.39 m TWD |
| Gross profit | 234.32 m TWD | 276.55 m TWD |
| Operating income | -2.42 m TWD | 17.92 m TWD |
| EBIT | -3.78 m TWD | 17.92 m TWD |
| Net income | 5.61 m TWD | 7.73 m TWD |
| Diluted EPS – continuing operations | 0.15 TWD | 0.20 TWD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About MedImaging Integrated Solution Inc.
Medimaging Integrated Solution Inc. engages in the design, manufacture and sale of digital medical imaging diagnostic equipments. It also provides digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes, as well as auxiliary tools. It also offers horus scope products, including optical coherence tomography products, control units, scopes, software, and accessories; computing-based AI screening solutions in diabetic retinopathy, wound care, and medical diagnosis; endoscopy solutions comprising a micro camera module for visualization performance and patient-oriented care; and micro camera modules. The company was founded in 2010 and is headquartered in Hsinchu City, Taiwan.
More stocks
- Sam Jung Pulp (009770.KS)
- TALPHERA, INC. (TLPH)
- Coppernico Metals Inc. (COPR.TO)
- Ildong Holdings Co Ltd (000230.KS)
- Aplex Technology (6570.TWO)
- SuNam Co. Ltd (294630.KQ)
- Daekyo (019680.KS)
- Max Echo Technology Corp. (5228.TWO)
- Korea Refract (010040.KS)
- Sunflex Tech Co Ltd (3390.TWO)
- Lida Holdings Ltd (4552.TW)
- Datacentrex, Inc. (DTCX)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.